Cargando…
COVID-19 Virus Infection in Three Patients With Hypogammaglobulinemia
The world is experiencing the COVID-19 outbreak and there are no evidence-based treatment strategies available for immunocompromised patients. COVID-19 is a novel beta coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with cancer are more susceptible to infe...
Autores principales: | Gesiotto, Quinto, Cheema, Asima, Avaiya, Kishan, Shah, Bijal, Greene, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231731/ https://www.ncbi.nlm.nih.gov/pubmed/34188994 http://dx.doi.org/10.7759/cureus.15256 |
Ejemplares similares
-
COVID-19 in Patients With Hematologic-Oncologic Risk Factors: Complications in Three Patients
por: Tafti, Dawood, et al.
Publicado: (2020) -
Reduced Community-acquired Respiratory Virus Infection, but Not Non–virus Infection, in Lung Transplant Recipients During Government-mandated Public Health Measures to Reduce COVID-19 Transmission
por: Keller, Brian C., et al.
Publicado: (2023) -
Secondary Bacterial Infection Rates Among Patients With COVID-19
por: Bahceci, Ilkay, et al.
Publicado: (2022) -
Reactogenicity of COVID-19 Vaccines in Patients With a History of COVID-19 Infection: A Survey Conducted in Pakistan
por: Riyyan, Muhammad, et al.
Publicado: (2022) -
Reactive Arthritis After COVID-19 Infection
por: Jali, Ibtisam
Publicado: (2020)